Dermocosmetic is not a separate legal class; it is positioning and evidence language. The same cosmetics rules apply. The difference is actives tied to clinical literature, tighter irritation management and restrained claims.
Clinic-channel sales do not mean “speak like a drug”; post-procedure use cases should be written clearly. Ceres ranges split those cases by skin type and aftercare need.
On the line the difference shows in intake and in-process controls. A low-pH peel, high SPF or alcohol disinfectant does not run at the same recipe speed. Weighing precision and filling kit are SKU-specific.
For the brand, the dermocosmetic promise raises test and PIF cost but builds trust in clinic and pharmacy. Köni Kimya backs that promise with manufacturing standards; it does not write the marketing line alone.